Autolus Therapeutics PLC reports results for the quarter ended in September - Earnings Summary

Autolus Therapeutics

03/11/2022 14:18

* Autolus Therapeutics PLC  AUTL.OQ  reported a quarterly
adjusted
loss of 47 cents​​ per share for the quarter ended in September.
The mean expectation of nine analysts for the quarter was for a
loss of 46 cents per share.
    * Revenue rose 903.8% to $2.37 million from a year ago;
analysts
expected $135.00 thousand. 
    * Autolus Therapeutics PLC's reported EPS for the quarter
was a
loss of 47 cents​.
    * The mean earnings estimate of analysts had fallen by
about 3.5%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Autolus Therapeutics PLC shares had risen by 29.9% this
quarter and lost 46.4% so far this year.
    * The company reported a quarterly loss of $42.77 million.
    * Wall Street's median 12-month price target for Autolus
Therapeutics PLC is $11.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
3 at 02:18 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.46          -0.47          Missed
 Jun. 30 2022      -0.42          -0.46          Missed
 Mar. 31 2022      -0.48          -0.41          Beat
 Dec. 31 2021      -0.46          -0.51          Missed